|SEQ_NO||1||Date of announcement||2022/02/16||Time of announcement||13:35:53|
|Subject||Announcement of TTY Biopharm's unaudited income information in January 2022|
|Date of events||2022/02/16||To which item it meets||paragraph 53|
|Statement||1.Date of occurrence of the event:2022/02/16
2.Company name:TTY Biopharm Co., Ltd.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $407,527 thousands (expressed in NT dollars; unaudited), a consolidated operating profit of $108,874 thousands, and a consolidated income before tax of $116,730 thousands in January 2022; net income attributed to stockholders of the parent company was $89,688 thousands; EPS is $0.36.
7.Any other matters that need to be specified:
The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail.